Livingston Knights Donate $3,600 to Cure Breast Cancer Foundation

The Livingston Knights, the travel arm of Livingston Little League, have stepped up to the plate in support of breast cancer research, raising more than $3,600 for the Cure Breast Cancer Foundation (CBCF) through a special apparel fundraiser.

The Knights, which include 10 teams and more than 125 players, sold limited-edition pink Knights-branded sweatshirts and hats throughout October in honor of Breast Cancer Awareness Month. The initiative brought together teammates, families, and the greater Livingston community in support of CBCF’s mission to advance groundbreaking research led by Dr. Larry Norton and his team at Memorial Sloan Kettering Cancer Center.

Jeff Krantz, General Manager of the Livingston Knights, shared his pride and appreciation for the team’s effort, saying, “This fundraiser truly shows what makes youth sports so special. It’s not just about baseball, it’s about teamwork, compassion, and giving back. Our players and families embraced this cause with incredible enthusiasm. As a cancer survivor myself, and having watched my mother battle breast cancer, this effort is deeply personal to me. Dr. Norton’s research is life changing for so many, and it means so much that our Knights community could play a small part in helping move that mission forward.”

One hundred percent of proceeds from the fundraiser were donated directly to CBCF. The effort was spearheaded by Knights moms Danielle Stein and Jamie Glazer, who led the initiative from concept to completion. Glazer is also a former member of CBCF’s Junior Board.

“We are so grateful to the Livingston Knights for their generosity and community spirit,” said Andrew Abramson, Co-Founder and Treasurer of the Cure Breast Cancer Foundation. “Community-driven support like this plays a vital role in helping us advance the research that brings us closer to a cure.”

Since its founding in 2007, the Cure Breast Cancer Foundation has raised more than $13 million to fund breast cancer research focused on innovations in the self-seeding theory of breast cancer.